Eco-friendly and cost-effective biosurfactants derived from waste
Ghent-based start-up will revolutionize the surfactant market: AmphiStar secures €6 million
European Circular Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF) have joined forces to provide a significant boost to Ghent-based start-up AmphiStar. The funding round, led by ECBF, raised €6 million. This will allow AmphiStar to accelerate the industrialization of its biosurfactants range and strengthen its team. To manage this accelerated transition, Pierre-Franck Valentin joined the team as CEO. As AmphiStar gears up for full commercial deployment, the company is laying the groundwork for future expansion with plans for the construction of a 1.000 tonnes (100% active) per annum launch plant.
AmphiStar
Waste derived biosurfactants to revolutionize sustainability in everyday products
Surfactants play a pivotal role as functional components in numerous products in our daily lives, ranging from shampoos to toothpastes, cosmetics, inks, paints, agrochemicals, food and feed and even construction materials. Over 20 million tonnes of surfactants are produced every year, of which the vast majority are relying heavily on unsustainable fossil- and/or palm oil feedstocks and are produced using harsh traditional chemical manufacturing processes.
AmphiStar is revolutionizing the surfactant market by introducing microbial biosurfactants produced from locally sourced waste- and side- streams from the agri-food industry, such as supermarket food waste. These innovative, circular biosurfactants do not compete with food production nor do they directly impact land use. Moreover, mild and safe biological processes similar to brewing beer are applied for their production. AmphiStar offers a comprehensive portfolio of biobased, biologically produced, and biocompatible glycolipids, such as sophorolipids, to brand owners of cleaning- and cosmetic products seeking genuinely sustainable, high-performing, and affordable alternatives. These biosurfactants come in various forms and purities, serving as perfect drop-in replacements for existing formulations while significantly reducing the carbon footprint of finished products. This is only the start as AmphiStars’ biosurfactants have the potential to be used in many different markets and applications using surfactants as such revolutionizing an entire sector.
Investment accelerates market penetration of new biosurfactant generation and fuels Amphistar’s expansion plans
The infusion of €6 million in new capital from ECBF, Qbic III and FFTF will empower AmphiStar to kickstart commercial biosurfactant production in collaboration with external partners. The investment will also be used to enhance R&D efforts to further refine and optimize its biosurfactant platform, complete the regulatory and certification dossiers and engineer its own state-of-the-art production facility. AmphiStar will raise more funding in 2025 for construction of the production facility and plans to hire 15 new employees within the year to bolster its expansion efforts.
AmphiStar, a pioneer in waste based biosurfactants
AmphiStar, established in 2021, is a spin off company from Ghent University and the Bio Base Europe Pilot Plant. The company builds on over 15 years of world class deep tech research and scaling expertise and has a strong IP base. The company is considered as one of the world references and pioneers in this field and is run by a strong team with a broad complementary skillset, including industrial and start-up experience, synthetic biology, process development, scale up, formulation and commercialization.
CEO with experience in surfactants and chemical industry
Last but not least, AmphiStar was able to attract an experienced business leader to strengthen the team. Pierre-Franck Valentin has 25+ years of business experience in the surfactants and chemicals‘ industries and will join the team as CEO. His experience and network will allow the company to speed up its market traction and fulfill its ambitions to become a world leader in the (bio)surfactant space.
Sophie Roelants, AmphiStar: “AmphiStar will revolutionize the surfactant market. We have developed a unique platform technology and are the only company in the (bio)surfactant space successfully combining a set of different key technologies: waste- and side stream technologies, synthetic biology, bioprocessing, purification and scaling expertise. With this capital injection and extended support of these prominent investors we will bring our unique waste based biosurfactant products to market and aim to make biosurfactants mainstream. We have had a first market introduction of one of our waste based biosurfactants with Ecover last year, showcasing the performance, safety and sustainability of our waste based sophorolipids. We are looking for more sustainable partnerships and are open to collaborate. We are also looking for enthousiastic new talent to strengthen our team.”
Jowita Sewerska, Investment Director European Circular Bioeconomy Fund (ECBF): “There is a clear market need for a better biosurfactants’ offer from the producers – in terms of performance, sustainability and price points. AmphiStar has great cards to play here and is now at an exciting point of accelerating the commercialization of its products.”
Sofie Baeten, Managing Partner Qbic III: “As an early supporter of AmphiStar, we are thrilled to continue our shared mission of driving sustainable innovation. Leveraging over 15 years of cutting-edge research at Ghent University, AmphiStar’s technology enables the cost-efficient and ecological production of biosurfactants from renewable feedstocks, advancing the transition to a circular economy. We proudly support their efforts to drive a greener, bio-based industry, and look forward to the impactful outcomes of our collaboration in shaping a sustainable future.”
Vincent Hebbelynck, Business manager FFTF: “This round financing will enable to further develop the promising sustainable technology of AmphiStar, originating in Flemish universities and research organisations, towards broad market adoption. It hits the sweet spot of the investment focus of Flanders Future Tech Fund.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
